Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

Jeremy M. Shefner; Merit E. Cudkowicz; Angela Genge; Orla Hardiman; Ammar Al-Chalabi; Jinsy A. Andrews; Adriano Chio; Philippe Corcia; Philippe Couratier; Mamede De Carvalho; et al.

doi:10.1001/jamaneurol.2025.0241

Back

Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

Journal article

Peer reviewed

Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

Jeremy M. Shefner, Merit E. Cudkowicz, Angela Genge, Orla Hardiman, Ammar Al-Chalabi, Jinsy A. Andrews, Adriano Chio, Philippe Corcia, Philippe Couratier, Mamede De Carvalho, …

JAMA neurology, Vol.82(5), pp.477-485

05/01/2025

DOI: https://doi.org/10.1001/jamaneurol.2025.0241

PMID: 40126464

Files and links (1)

url

https://doi.org/10.1001/jamaneurol.2025.0241View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial
Creators: Jeremy M. Shefner - Creighton University
Merit E. Cudkowicz - Harvard University
Angela Genge - Montreal Neurological Institute and Hospital
Orla Hardiman - Trinity College Dublin
Ammar Al-Chalabi - King's College London
Jinsy A. Andrews - The Neurological Institute
Adriano Chio - University of Turin
Philippe Corcia - Centre Hospitalier Universitaire de Tours
Philippe Couratier - Hôpital Dupuytren
Mamede De Carvalho - University of Lisbon
et al.
Publication Details: JAMA neurology, Vol.82(5), pp.477-485
Number of pages: 9
Grant note: Cytokinetics (http://data.elsevier.com/vocabulary/SciValFunders/100014941) Pharma Inc
Identifiers: 991006262111002656
Academic Unit: Neurology
Language: English
Resource Type: Journal article